FDA approved Pylarify TruVu, a higher-radioactivity-concentration formulation of piflufolastat F 18 designed to increase batch size and distribution efficiency while maintaining the established ...

Colorectal cancer is highly preventable, and early detection saves lives. Colon Cancer Awareness Month is an ideal time for ...

March is Colon Cancer Awareness Month. It’s the 4th most common cancer in men and women, and continues to have an impact nationally and locally. Data from the Centers for Disease ...

Reconstructive surgery may be needed after a large tumor is removed. Reconstructive surgery helps to rebuild the area and restore how the throat works. Your surgeon will often take tissue and blood ...

You may be reading this because you or someone you care about has nasal cavity or sinus cancer. Learning more can help you get ready to talk with your healthcare provider and understand the next steps ...

As 10-year-old Andryk Williams of Fort Blackmore, Virginia, prepares for his next round of cancer treatment at St. Jude ...

For asymptomatic people without known risks, the downsides and uncertainties of multi-cancer early detection testing could ...

A study of couples across four countries underscores partner inclusion, structured screening, and immediate referral to psycho-oncology to prevent maladaptive coping.

Among patients with no history of cancer, the tool achieved a prediction accuracy rate of 50%.

“This is cryoablation of breast cancer,” Dr. Katelin Holmes, a breast and surgical oncologist at Thomas Hospital, said.

Two small-cap biotech names made serious noise today. Xenon Pharmaceuticals (XENE) is trading at $62.76, up 49.6% today, while Relmada Therapeutics (RLMD) sits at $7.17, also up 61.1% Both moves were ...